breseq  version 0.33.1  revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log

Marginal read alignment evidence
  seq id position ref new freq score (cons/poly) reads annotation genes product
*USA300TCH1516_ALE512,6430AG52.1% 12.5 / 286.8 194intergenic (+711/‑6052)recR/speA_2Recombination protein RecR/Arginine decarboxylase
*USA300TCH1516_ALE111,5120AG34.7% 150.7 / 110.7 124S194S (TCA→TCGUSA300HOU_RS00520putative lipoprotein
*USA300TCH1516_ALE111,5160CA33.6% 197.8 / 105.3 123Q196K (CAA→AAA) USA300HOU_RS00520putative lipoprotein

Marginal new junction evidence (lowest skew 10 of 23 shown)
  seq id position reads (cov) reads (cov) score skew freq annotation gene product
* ? USA300TCH1516_ALE = 80214198 (1.090)6 (0.070) 6/256 12.0 6.3% intergenic (+382/+242) USA300HOU_RS03915/USA300HOU_RS03920 Putative 5'(3')‑deoxyribonucleotidase/Putative lipid kinase
?USA300TCH1516_ALE = 802168 88 (1.060)intergenic (+409/+215) USA300HOU_RS03915/USA300HOU_RS03920 Putative 5'(3')‑deoxyribonucleotidase/Putative lipid kinase
* ? USA300TCH1516_ALE 382471 =92 (1.020)4 (0.050) 4/256 13.4 4.4% intergenic (+4/+89) USA300HOU_RS01745/ulaA UDP‑glucose 4‑epimerase/Ascorbate‑specific PTS system EIIC component
?USA300TCH1516_ALE 382543 = 89 (1.070)intergenic (+76/+17) USA300HOU_RS01745/ulaA UDP‑glucose 4‑epimerase/Ascorbate‑specific PTS system EIIC component
* ? USA300TCH1516_ALE 48947 =92 (1.020)5 (0.060) 4/258 13.5 5.6% intergenic (‑56/+178) hin_2/USA300HOU_RS00205 DNA‑invertase hin/hypothetical protein
?USA300TCH1516_ALE 48972 = 82 (0.980)intergenic (‑81/+153) hin_2/USA300HOU_RS00205 DNA‑invertase hin/hypothetical protein
* ? USA300TCH1516_ALE 2679162 =83 (0.920)5 (0.060) 4/266 13.8 5.9% intergenic (+34/‑355) USA300HOU_RS13790/ssaA2_4 hypothetical protein/Staphylococcal secretory antigen ssaA2
?USA300TCH1516_ALE 2679186 = 80 (0.930)intergenic (+58/‑331) USA300HOU_RS13790/ssaA2_4 hypothetical protein/Staphylococcal secretory antigen ssaA2
* ? USA300TCH1516_ALE 1117293 =98 (1.090)3 (0.040) 3/248 13.9 3.3% intergenic (+6/+148) suhB_1/USA300TCH1516_01040 Inositol‑1‑monophosphatase/hypothetical protein
?USA300TCH1516_ALE 1117341 = 88 (1.090)intergenic (+54/+100) suhB_1/USA300TCH1516_01040 Inositol‑1‑monophosphatase/hypothetical protein
* ? USA300TCH1516_ALE 2497906 =106 (1.180)3 (0.040) 3/256 14.2 3.0% intergenic (+11/+75) USA300HOU_RS12865/treP_2 hypothetical protein/PTS system trehalose‑specific EIIBC component
?USA300TCH1516_ALE 2497975 = 97 (1.170)intergenic (+80/+6) USA300HOU_RS12865/treP_2 hypothetical protein/PTS system trehalose‑specific EIIBC component
* ? USA300TCH1516_ALE 1683113 =96 (1.060)3 (0.040) 3/256 14.2 3.6% coding (145/699 nt) USA300HOU_RS08385 hypothetical protein
?USA300TCH1516_ALE 1683167 = 72 (0.870)coding (91/699 nt) USA300HOU_RS08385 hypothetical protein
* ? USA300TCH1516_ALE 1628158 =106 (1.180)4 (0.050) 3/254 14.2 3.8% coding (315/1407 nt) gnd 6‑phosphogluconate dehydrogenase, decarboxylating
?USA300TCH1516_ALE 1628226 = 103 (1.250)coding (247/1407 nt) gnd 6‑phosphogluconate dehydrogenase, decarboxylating
* ? USA300TCH1516_ALE 2857675 =81 (0.900)3 (0.040) 3/258 14.3 3.9% intergenic (+71/‑172) nixA/nhoA High‑affinity nickel‑transport protein NixA/N‑hydroxyarylamine O‑acetyltransferase
?USA300TCH1516_ALE 2857737 = 74 (0.880)intergenic (+133/‑110) nixA/nhoA High‑affinity nickel‑transport protein NixA/N‑hydroxyarylamine O‑acetyltransferase
* ? USA300TCH1516_ALE 2640242 =95 (1.050)3 (0.040) 3/258 14.3 3.2% intergenic (‑94/+60) rspR/zntR HTH‑type transcriptional repressor RspR/HTH‑type transcriptional regulator ZntR
?USA300TCH1516_ALE 2640290 = 92 (1.100)intergenic (‑142/+12) rspR/zntR HTH‑type transcriptional repressor RspR/HTH‑type transcriptional regulator ZntR